Ben Daverman joined GTCR in 2008 as a Vice President. Prior to joining GTCR, he worked as a venture capitalist at Alta Partners, as well as an investment banking Associate at JMP Securities and an Analyst in the Mergers & Acquisitions group at J.P. Morgan (formerly Hambrecht & Quist). He holds an MBA from the Wharton School at the University of Pennsylvania and a BA in history magna cum laude from Colgate University. Ben also holds a master’s degree in biotechnology from the School of Applied Sciences & Engineering at the University of Pennsylvania. He currently is a Director of Cord Blood Registry, Crealta Pharmaceuticals, Devicor Medical Products, Maravai Life Sciences, Sterigenics and XIFIN. Ben was previously a Director of past GTCR investments such as Actient Pharmaceuticals and GeneraMedix. In addition, Ben was heavily involved in GTCR’s investment in Graceway Pharmaceuticals.